Science

Kevin Boehm: Multimodal histopathologic models stratify HR+ early breast cancer

Kevin Boehm/doximity-res.cloudinary.com

Mar 4, 2025, 10:49

Kevin Boehm: Multimodal histopathologic models stratify HR+ early breast cancer

Kevin Boehm, Resident and Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared an article on LinkedIn:

“Good to see this in print. We built Orpheus, a model to infer OncoType score from H&E and pathology text reports, finding that multimodal data integration strengthens inference.

We also tuned directly on metastatic recurrence to refine TAILORx low/intermediate risk groups. The findings generalized empirically across American, Slovakian, and Italian test cohorts.

It was awesome to work with Sohrab Shah, Jakob Nikolas Kather, Omar El Nahhas, and Antonio Marra on this.

Orpheus code is open source for any academic applications.”

Multimodal histopathologic models stratify hormone receptor-positive early breast cancer.

Authors: Kevin M. Boehm, et al.

Kevin Boehm: Multimodal histopathologic models stratify HR+ early breast cancer

Read more articles on Breast Cancer.

Antonio Marra Breast Cancer cancer fight against cancer Global fight against cancer Jakob Nikolas Kather Kevin Boehm Memorial Sloan Kettering Cancer Center Omar El Nahhas OncoDaily Oncology Orpheus RadOnc Sohrab Shah TAILORx

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma